Healthcare Resources Available in Difficult Times -
Lilly Recognized as One of the World's Top Biopharmaceutical Employers -
Exhbiti to showcase art of cancer patients -
CREDIT SUISSE CUTS ELI LILLY TO NEUTRAL FROM OUTPERFORM - THEFLYONTHEWALL.COM -
Lilly resolves multi-state investigation of Zyprexa -
Eli Lilly and Company to announce financial results for third quarter 2008 -
Lilly Sets Date and Conference Call for Third Quarter 2008 Financial Results Announcement -
Eli Lilly to pay $62 million settlement -
UPDATE 1-Eli Lilly to pay $62 million in Zyprexa settlement -
CITIGROUP CUTS ELI LILLY PRICE TARGET TO $42 FROM $52; RATING HOLD -
BRIEF-Eli Lilly resolves investigation involving Zyprexa -
ELI LILLY AND CO SAYS PAYMENT WILL RESULT IN 3Q CHARGE OF $.04 PER SHARE -
ELI LILLY AND CO SAYS TO PAY $62M TO BE DIVIDED AMONG THE SETTLING STATES -
Eli Lilly and Company Resolves Investigation Involving Numerous States -
Fitch Places Eli Lilly's 'AA' IDR on Watch Negative on ImClone Merger -
Eli Lily to acquire ImClone Systems Inc. -
Lilly to acquire ImClone Systems for $6.5 billion -